“…Survival time ranged from 1 to 32 mo. The 177 WJGO|www.wjgnet.com July 15, 2012|Volume 4|Issue 7| Hisamoto et al [6] [5] 60 F Present Nodule Umbilicus Tail 2 mo, dead Peritoneum Chemotherapy Yoneda et al [11] 53 F Absent Nodule Umbilicus Tail 7 mo, dead Peritoneum Chemotherapy Yoneda et al [11] 64 F Absent Nodule Umbilicus Body 8 mo, alive Lung Chemotherapy Crescentini et al [12] 75 M Present Nodule Umbilicus Body 6 mo, dead Liver GEM Okazaki et al [13] [22] 50 M Present Nodule Lateral abdomen Body 2 mo, dead Liver, brain GEM, irinotecan Kimura et al [23] 68 M Absent Nodule Umbilicus Body 4 mo, dead Liver, LN GEM, UFT-E, RT Yamashita et al [24] 72 F Present Nodule Umbilicus Tail 32 mo, dead Peritoneum GEM, S-1 Hirahara et al [25] 67 F Present Nodule Lower abdomen Tail 3 mo, dead Liver, LN GEM Pontinen et al [26] 70 F Present Nodule Umbilicus Tail 4 mo, dead Liver, peritoneum GEM Ozaki et al [27] 81 M Present Nodule Umbilicus Tail 7 mo, dead Peritoneum S-1 Ozaki et al [27] 59 M Absent Nodule Umbilicus Body 11 mo, alive Liver, peritoneum GEM, 5-FU Ozaki et al [27] 66 M Absent Nodule Umbilicus Body 18 mo, dead Liver GEM, 5-FU Ozaki et al [27] median survival time (MST) of all patients was 5 mo after diagnosis of cutaneous metastases. The cumulative 1-and 2-year survival rate was 17.5% and 3.5%, respectively ( Figure 1A).…”